Is electrical storm in ICD patients the sign of a dying heart?: Outcome of patients with clusters of ventricular tachyarrhythmias

Europace

Volumn 2, Issue 3, 2000, Pages 263-269

  Greene, M ^a   Newman, D ^a   Geist, M ^a   Paquette, M ^a   Heng, D ^a   Dorian, P ^a  

^a NONE

Author keywords

Antiarrhythmia agents; Electrical storm; Implantable cardioverter defibrillators; Survival

Indexed keywords

ARTICLE; COMPARATIVE STUDY; DEFIBRILLATOR; FEMALE; HEART TRANSPLANTATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY;

DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 0034232526     PISSN: 10995129     EISSN: None     Source Type: Journal    
DOI: 10.1053/eupc.2000.0104     Document Type: Article

References (33)

1. Kowey PR, Marinchak RA, Rials SJ, Rubin AM, Smith L. Electrophysiologic testing in patients who respond acutely to intravenous amiodarone for incessant ventricular tachyarrhythmias. Am Heart J. 125:1993;1628-1632.
2. Villacastin J, Almendral J, Arenal A, Albertos J, Ormaetxre J, Peinado R, Bueno H, Merino JL, Pastor A, Medina O, Tercedor L, Jimenez F, Delcan JL. Incidence and clinical significance of multiple consecutive, appropriate, high-energy discharges in patients with implanted cardioverter-defibrillators. Circulation. 93:1996;753-762.
3. Credner SC, Klingenheben T, Mauss O, Sticherling C, Hohnloser SH. Electrical storm in patients with transvenous implantable cardioverter-defibrillators. Incidence, management and prognostic implications. J Am Coll Cardiol. 32:1998;1909-1915.
4. Kowey PR, Levine JH, Herre JM, Pacifico A, Lindsay BD, Plumb VJ, Janosik DL, Kopelman HA, Scheinman MM. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. Circulation. 92:1995;3255-3263.
5. Scheinman MM, Levine JH, Cannom DS, Friehling T, Kopelman HA, Chilson DA, Platia EV, Wilber DJ, Kowey PR. Dose ranging study in intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. Circulation. 92:1995;3264-3272.
6. Levine JH, Massumi A, Scheinman MM, Winkle RA, Platia EV, Chilson DA, Gomes JA, Woosley RL. Intravenous amiodarone for recurrent sustained hypotensive ventricular tachycardia. J Am Coll Cardiol. 27:1996;67-75.
7. Jung W, Manz M, Pfeiffer D, Tebbenjohanns J, Pizzulli L, Luderitz B. Effects of antiarrhythmic drugs on epicardial defibrillation energy requirements and the rate of defibrillator discharges. Pacing Clinical Electrophysiol. 16:1993;198-201.
8. Jung W, Manz M, Pizzulli L, Pfeiffer D, Lüderitz B. Effects of chronic amiodarone therapy on defibrillation threshold. Am J Cardiol. 70:1992;1023-1027.
9. Daoud EG, Ching Man K, Horwood L, Morady F, Strickberger SA. Relation between Amiodarone and desethylamiodarone plasma concentrations and ventricular defibrillation energy requirements. Am J Cardiol. 79:1997;97-100.
10. Gottleib CD, Horwitz LN. Potential interactions between the antiarrhythmic medication and the automatic implantable cardioverter defibrillator. Pacing Clinical Electrophysiol. 14:1991;898-904.
11. N Engl J Med. 337:1997;1576-1583.
12. Khono T, Bhandari AK, Park Y, Hollman A, Lerman RD, Cannom DS. Cluster shocks in patients with third generation implantable cardioverter defibrillators: Frequency, mechanisms and clinical significance. Pacing Clinical Electrophysiol. 18:1995;846.
13. Kluger J, Veronneau J, Fisher J. Cluster shocks: a strong predicter of subsequent mortality in patients with internal cardioverter defibrillators (Abstr). Pacing Clinical Electrophysiol. 18:1995;845.
14. Nunain SO, Roelke M, Trouton T, Osswald S, Kim YH, Sosa-Suarez G, Brooks DR, McGovern B, Guy M, Torchiana DF, Vlahakas GJ, Garan H, Ruskin JN. Limitations and late complications of third generation automatic cardioverter-defibrillators. Circulation. 91:1995;2204-2213.
15. Greenberg YJ, MacPherson CA, Lewis RJ, Batsford WP, Rosenfeld LE. Etiology, therapy and prognosis of incessant defibrillator discharges (Abstr). Circulation. 92:1995;I-605.
16. Bardy GH, Yee R, Jung W. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. J Am Coll Cardiol. 28:1996;400-410.
17. Myerburg RJ, Luceri RM, Thurer R, Cooper DK, Zaman L, Interian A, Fernandez P, Cox M, Glicksman F, Castellanos A. Article title. J Am Coll Cardiol. 14:1989;508-514.
18. Tebbenjohanns J, Schumacher B, Jung W, Korte T, Pfeiffer D, Manz M, Lüderitz B. Predictors of outcome in patients with implantable transvenous cardioverter defibrillators. Am Heart J. 127:1994;1086-1089.
19. Marchant B, Ranjadayalan K, Stevenson R, Wilkinson P, Timis AD. Circadian and seasonal factors in the pathogenesis of acute myocardial infarction: The influence of temperature. Br Heart J. 69:1993;385-387.
20. Enquselassie F, Dobson AJ, Alexander HM, Steele PL. Seasons, temperature, and coronary disease. Int J Epidemiol. 22:1993;632-636.
21. Douglas AS, Al-Sayer H, Rawles JM, Allan TM. Seasonality of disease in Kuwait. Lancet. 331:1991;1393-1397.
22. Douglas AS, Dunnigan MG, Allan TM, Rawles JM. Seasonal variation in coronary heart disease in Scotland. J Epidemiol Comm Health. 49:1995;575-582.
23. Anderson TW, LeRiche WH. Cold weather and myocardial infarction. Lancet. 1:1970;291-296.
24. Leor J, Poole WK, Kloner RA. Sudden cardiac death triggered by an earthquake. N Engl J Med. 334:1996;413-419.
25. Nishimoto Y, Firth BR, Kloner RA, Leor J, Lerman RD, Bhandari AK, Cannom DS. The 1994 Northridge earthquake triggered shocks from implantable cardioverter defibrillators (Abstr). Circulation. 92:1995;I-605.
26. Meisel SR, Kutz I, Dayan KI, Pauzner H, Chetboun I, Arbel Y, David D. Effect of Iraqi missile war on incidence of acute myocardial infarction and sudden death in Israeli citizens. Lancet. 338:1991;660-661.
27. Mittleman MA, Maclure M, Sherwood J, Mulry RP, Tofler GH, Jasobs SC, Friedman R, Benson H, Muller JE. Triggering of acute myocardial infarction onset by episodes of anger. Circulation. 92:1995;1720-1725.
28. Dorian P, Newman DM, Sheehan R, Tang A, Green M, Mitchell J. d-Sotalol decreases defibrillation energy requirements in humans: a novel indication for drug therapy. J Cardiovasc Electrophysiol. 7:1996;952-961.
29. Ochi RP, Goldenberg IF, Almquist A, Pritzker M, Milstein S, Pedersen W, Gobel FL, Benditt DG. Intravenous amiodarone for the treatment of life threatening ventricular arrhythmias in critically ill patients with coronary artery disease. Am J Cardiol. 64:1989;599-603.
30. Greene HL. The CASCADE study: Randomized antiarrhythmic drug therapy in survivors of cardiac arrest in Seattle. Am J Cardiol. 72:1993;70F-74F.
31. Dolack GL. Clinical predictors of implantable cardioverter-defibrillator shocks (results of the CASCADE trial). Am J Cardiol. 73:1994;237-241.
32. Miller JM, Hsia HH. Management of the patient with frequent discharges from implantable cardioverter defibrillator devices. J Cardiovasc Electrophysiol. 7:1996;278-285.
33. Marchlinski FE, Buxton AE, Kindwall EK, Miller JM, Rosentahl ME, Gottlieb CD, Bloom RB, Josephson ME. Comparison of individual and combined effects of procainamide and amiodarone in patients with sustained ventricular tachyarrhythmias. Circulation. 78:1988;583-591.